Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression.
(Q39874679)
scientific article published on 10 March 2009
scientific article published on 10 March 2009
Language:
other details
| description | scientific article published on 10 March 2009 |
External Links
| (P356) |
10.1158/0008-5472.CAN-08-3563
|
| (P698) |
19276360
|
| (P8608) |
release_bowzz43ahngh5k552ojvvoio5e
|